|
2025
|
G/S
|
Chemical products for use in industry and science; chemical preparations for scientific use, othe... |
|
|
G/S
|
Chemical products for use in industry and science; chemical
preparations for scientific use, oth... |
|
2023
|
Invention
|
Polynucleotides and lentiviral vectors expressing non-structural antigens of a flavivirus selecte... |
|
|
Invention
|
Lentiviral vectors for expression of human papillomavirus (hpv) antigens and its implementation i... |
|
|
Invention
|
Boosting sars-cov-2 immunity with a lentiviral-based nasal vaccine.
The invention relates to the... |
|
|
Invention
|
Boosting sars-cov-2 immunity with a lentiviral-based nasal vaccine. The invention relates to the ... |
|
2022
|
Invention
|
Lentiviral vector for expression of human papillomavirus (hpv) antigens and its implementation in... |
|
|
Invention
|
Lentiviral vector, lentiviral particle for treating hepatitis b and its preparation method and ap... |
|
|
Invention
|
Lentiviral vectors targeting antigens to mhc-ii pathway and inducing protective cd8+ and cd4+ t-c... |
|
2021
|
Invention
|
A new hace2 transgenic animal with remarkable permissiveness of lung and central nervous system t... |
|
|
Invention
|
Lentiviral vectors enabling routing antigens to mhc-ii pathway and inducing cd4+ and cd8+ t-cell ... |
|
|
Invention
|
High throughput methods and products for sars-cov-2 sero-neutralization assay.
Pseudotyped lenti... |
|
|
Invention
|
High throughput methods and products for sars-cov-2 sero-neutralization assay. Pseudotyped lentiv... |
|
|
Invention
|
Sars-cov-2 immunogenic compositions, vaccines, and methods.
A method of inducing a protective im... |
|
|
Invention
|
Sars-cov-2 immunogenic compositions, vaccines, and methods. A method of inducing a protective imm... |
|
2020
|
Invention
|
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule.
The inventi... |
|
2019
|
G/S
|
Vaccines for human or veterinary use; vaccines for human or veterinary, therapeutic or prophylact... |
|
|
G/S
|
Vaccines for human or veterinary use; vaccines for human or
veterinary, therapeutic or prophylac... |
|
2017
|
Invention
|
Use of non-subtype b gag proteins for lentiviral packaging.
The invention encompasses a lentivir... |
|
|
Invention
|
Lentiviral vectors for expression of hepatitis b virus (hbv) antigens. The invention relates to n... |
|
2016
|
Invention
|
Lentiviral vectors for expression of mycobacterium tuberculosis antigens. The invention relates t... |
|
2015
|
Invention
|
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule. The inventio... |
|
|
G/S
|
Chemical products for scientific use; chemical products for
analysis in laboratories; diagnostic... |
|
|
Invention
|
Lentiviral vectors for generating immune responses against human t lymphotrophic virus type 1. Th... |
|
2014
|
Invention
|
Lyophilized lentiviral vector particles, compositions and methods. Methods of making lyophilized ... |
|
|
Invention
|
Lentiviral vectors for expression of hiv-1 antigens. The present invention relates to the intramu... |
|
|
Invention
|
Lentiviral vectors for inducing cd4+ and cd8+ immune responses in vaccination of humans. The pres... |
|
|
Invention
|
Lentiviral vectors for inducing cd4+ and cd8+ immune responses in vaccination of humans infected ... |
|
|
Invention
|
Lentiviral vectors containing an mhc class i, mhc class ii, or b2 microglobulin upstream promoter... |
|
|
Invention
|
Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream prom... |
|
|
Invention
|
Lentiviral gene transfer vectors and their medicinal applications. The present invention relates ... |
|
2013
|
Invention
|
Glycoproteins for pseudotyping lentivectors.
The invention relates to compositions and methods b... |
|
|
Invention
|
Glycoproteins for pseudotyping lentivectors. The invention relates to compositions and methods ba... |
|
|
Invention
|
Lentiviral vectors containing an mhc class i promoter. The present invention relates to the inser... |
|
2012
|
Invention
|
Use of non-subtype b gag proteins for lentiviral packaging. The invention encompasses a lentivira... |
